Cheruvu Pavan 4
4 · Axovant Gene Therapies Ltd. · Filed Jun 17, 2019
Insider Transaction Report
Form 4
Cheruvu Pavan
Chief Executive Officer
Transactions
- Purchase
Common Stock
2019-06-14$5.21/sh+7,500$39,075→ 7,500 total
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.9798 to $5.35 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.